title: Effects of tenoten on anxiety and depression disorders in patients with epilepsy.
abstract: The efficiency and safety of tenoten for anxiety and depression disorders in epileptics has been demonstrated. The drug does not change the incidence and severity of epileptic episodes, does not deteriorate the course of the underlying disease, and can be well combined with anticonvulsants. The results indicate the efficiency of tenoten used to arrest the anxio-depressive disorders in epilepsy.
authors.affiliation: Department of Neurology and Neurosurgery, NI Pirogov Russian National Medical University, Ministry of Health and Social Development of the Russian Federation, Moscow, Russia.
authors.forename: A B
authors.initials: AB
authors.lastname: Delger
authors.forename: G N
authors.initials: GN
authors.lastname: Avakyan
authors.forename: O M
authors.initials: OM
authors.lastname: Oleinikova
authors.forename: M A
authors.initials: MA
authors.lastname: Bogomazova
authors.forename: E A
authors.initials: EA
authors.lastname: Chromych
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Lagutin
mesh_terms: D000906:Antibodies / Q000276:immunology / Q000494:pharmacology*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000209:etiology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology; D004827:Epilepsy / Q000150:complications*; D005260:Female; D018682:GABA Agents / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D009418:S100 Proteins / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D018682:GABA Agents; D009418:S100 Proteins; C529609:tenoten